中耳炎
不错
渗出
医学
计算机科学
听力学
语音识别
外科
程序设计语言
作者
Rachel Connolly,Aye Paing,Tim Reeves,Devavrata Joshi,Veronica Kennedy,Jennifer Royds
出处
期刊:
[BMJ]
日期:2023-11-09
卷期号:383: p2314-p2314
被引量:10
摘要
On behalf of the Guideline CommitteeWhat you need to know • Refer patients with suspected otitis media with effusion (OME), for age and developmentally appropriate assessment of hearing so OME can be diagnosed and potential hearing loss investigated • Do not use antibiotics, oral or nasal steroids, antihistamines, leukotriene receptor antagonists, mucolytics, proton pump inhibitors or anti-reflux medications, or decongestants for treatment • Consider off-label use of non-ototoxic topical antibiotic drops, such as ciprofloxacin, in the treatment of otorrhoea after grommet insertion • Give information and advice to children, parents and carers on how children can be supported at home and in the educational setting to help mitigate the impact of OME and associated hearing loss Otitis media with effusion (OME), commonly known as glue ear, is the presence of fluid in the middle ear in the absence of infection.It differs from acute otitis media, which is an infective condition and often presents with ear pain and discharge.Across the United States and Europe, up to 80% of children are affected by OME by 4 years of age, but prevalence declines beyond 6 years of age. 1 Although OME does not always impact on hearing and many cases of OME resolve within 3 months, OME is the most common cause of temporary and fluctuating hearing impairment in childhood and can have a major impact on children.The National Institute for Health and Care Excellence (NICE) guideline covering otitis media with effusion in under 12s was first published in 2008. 2 This article summarises the 2023 guideline, focusing on updated recommendations relevant to primary care.
科研通智能强力驱动
Strongly Powered by AbleSci AI